Hypoglycemia is especially prevalent in patients with type 1 diabetes (T1D) treated with exogenous insulin, or T2D being treated with oral sulfonylurea agents or exogenous insulin [4,5]. The gene discussed is INS; the disease is type 1 diabetes mellitus.